Splenomegaly in dogs. Predictors of neoplasia and survival after splenectomy.
Splenomegaly confirmed by surgery or necropsy in 100 dogs was diagnosed histologically as benign neoplasia (n = 1), primary splenic malignancy (n = 59), neoplastic metastases (n = 6), and nonneoplastic disease (n = 34). Dogs with known systemic disease, such as lymphoma and mast cell tumor, that caused splenomegaly were not included in the study. Hemangiosarcoma was the most common splenic disease (43 cases). Overall mean age of the dogs was 10.7 years, the most common breed was German Shepherd dog, and 72 of the dogs weighed more than 21 kg. Dogs with anemia, nucleated red blood cells, abnormal red blood cell morphology, or splenic rupture had a significantly greater chance of having splenic neoplasia (P less than 0.002). A multivariable logistic regression analysis found that the presence of anemia and splenic rupture in dogs with splenomegaly was up to 69% accurate in predicting presence of splenic neoplasia. After splenectomy, the median survival time of dogs with splenic neoplasia was 13 weeks. For dogs with nonneoplastic splenomegaly it was at least 36 weeks.
Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins.
K A
KA
Johnson
B E
BE
Powers
S J
SJ
Withrow
M J
MJ
Sheetz
C R
CR
Curtis
R H
RH
Wrigley
D000740:Anemia / Q000150:complications; D000818:Animals; D004283:Dog Diseases / Q000175:diagnosis / Q000601:surgery*; D004285:Dogs; D005260:Female; D006394:Hemangiosarcoma / Q000175:diagnosis / Q000601:surgery / Q000662:veterinary*; D008297:Male; D011379:Prognosis; D012044:Regression Analysis; D013156:Splenectomy / Q000662:veterinary; D013160:Splenic Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000662:veterinary*; D013161:Splenic Rupture / Q000662:veterinary; D013163:Splenomegaly / Q000209:etiology / Q000601:surgery / Q000662:veterinary*